Following strong growth in 2020 due to COVID-19 and consumers stockpiling adult acetaminophen, in particular, analgesics is projected to see a small decline in overall value sales in Norway in 2021. The decline will be a result of a decline in COVID-19 infection cases and a successful vaccination roll-out in the country. However, sales will still be above pre-pandemic levels as there was a new wave of COVID-19 early in 2021 and also as some consumers have used analgesics to help with the side ef...

Euromonitor International’s Analgesics in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.